Welcome to our dedicated page for GE HealthCare Technologies news (Ticker: GEHC), a resource for investors and traders seeking the latest updates and insights on GE HealthCare Technologies stock.
GE HealthCare Technologies Inc. (NYSE: GEHC) is a leading global innovator in medical technology, pharmaceutical diagnostics, and digital solutions. The company operates through four main segments: Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Of these, the Imaging segment generates the majority of the company’s revenue.
GE HealthCare is dedicated to providing transformational medical technologies and services that enhance access to quality, affordable healthcare worldwide. Through its cutting-edge products and comprehensive solutions, the company aims to improve patient outcomes and streamline healthcare delivery.
Recent achievements include advancements in artificial intelligence (AI) integration within medical imaging, which supports more accurate and efficient diagnostics. The company is also involved in numerous partnerships with healthcare providers and research institutions to drive innovation and improve global healthcare standards.
Financially, GE HealthCare has showcased robust performance, with steady revenue growth and strong market presence. The company continuously invests in R&D to maintain its edge in the competitive healthcare industry. Their suite of products includes advanced imaging machines, ultrasound devices, patient monitoring systems, and contrast media for diagnostic imaging.
As part of a highly regulated industry, GE HealthCare adheres to strict compliance standards and maintains rigorous quality controls across its operations. The company actively engages with its community, although it reserves the right to monitor and manage public interactions to uphold professional and constructive discourse.
GE HealthCare Technologies (Nasdaq: GEHC) has announced the pricing of a secondary public offering of 13,281,302 shares of its common stock. The company will not receive any proceeds from the sale, as GE Aerospace plans to exchange these shares for debt held by Morgan Stanley Bank. Following this debt-for-equity exchange, Morgan Stanley & Co. will sell the shares to underwriters. J.P. Morgan, Citigroup, and Morgan Stanley are serving as lead joint book-running managers. The offering is expected to close on November 12, 2024, subject to customary conditions.
GE HealthCare Technologies (Nasdaq: GEHC) announced a secondary public offering of 13,281,302 shares of common stock. The company will not sell any shares or receive proceeds from the offering. GE Aerospace plans to exchange these shares for debt held by Morgan Stanley Bank before the offering closes. Morgan Stanley & Co. will then sell the shares to underwriters. J.P. Morgan, Citigroup, and Morgan Stanley are serving as lead joint book-running managers for the offering.
GE HealthCare (Nasdaq: GEHC) announced it will host its 2024 Investor Day on Thursday, November 21, 2024, at Nasdaq MarketSite in New York, NY. The event will feature presentations from the management team covering growth strategies, technology portfolio, and business vision. A technology showcase will be available for in-person attendees following the presentations. Registration is required for attendance. Investors can access the live webcast through the company's investor relations website, where related materials and replay will also be available.
GE HealthCare (GEHC) reported Q3 2024 financial results with revenues of $4.9 billion, up 1% year-over-year. Net income margin improved to 9.7% from 7.8%, while Adjusted EBIT margin increased to 16.3% from 15.4%. Diluted EPS rose to $1.02 from $0.83, and Free cash flow reached $651 million, up from $570 million. The company saw growth in U.S. markets and Pharmaceutical Diagnostics, offset by softness in China. The company raised the low end of its full-year 2024 Adjusted EBIT margin and Adjusted EPS guidance, while noting organic revenue growth is trending toward the lower end of the 1-2% range.
GE HealthCare has announced CareIntellect for Oncology, a new cloud-first application that uses generative AI to consolidate multi-modal patient data into a single view. This application aims to help clinicians quickly understand disease progression and inform proactive interventions. Key features include:
- Summarizing clinical notes and reports
- Organizing structured and unstructured data
- Supporting treatment response assessments
- Helping assess clinical trial eligibility
- Tracking adherence to treatment protocols
Initially focusing on prostate and breast cancer, CareIntellect for Oncology is designed to reduce the time clinicians spend reviewing patient histories from hours to minutes. Tampa General Hospital and UT Southwestern Medical Center will be early evaluators, with wider U.S. availability planned for 2025.
GE HealthCare (Nasdaq: GEHC) has unveiled its new AI Innovation Lab, showcasing five early-concept AI projects aimed at revolutionizing healthcare. These innovations include:
1. Health Companion: An agentic AI project to provide multi-disciplinary medical team insights.
2. Triple negative breast cancer recurrence prediction research with Emory University.
3. Care companion initiative for enhancing maternal and infant care.
4. Multi-modal X-ray foundation model for full-body imaging analysis.
5. AI-powered mammography screening efficiency tool.
Additionally, GE HealthCare has submitted a 510(k) to the FDA for an AI-powered fetal heart rate interpretation feature. These projects are part of GE HealthCare's broader AI and digital strategy, leveraging cloud technology to drive AI development at scale.
GE HealthCare, the GE HealthCare Foundation, and the Charles Antetokounmpo Family Foundation (CAFF) have launched 'Powering Milwaukee Forward', a $1 million philanthropic initiative to improve access to basic needs in Milwaukee's underserved communities. The program will grant funds to 10 local nonprofits, focusing on social determinants of health such as fair housing, education, healthy food, safe physical environments, and maternal healthcare.
The initiative aims to address significant health disparities in Milwaukee, which are exacerbated by racial and socio-economic conditions. Giannis Antetokounmpo, founder of CAFF, expressed his commitment to supporting underserved neighborhoods. Peter J Arduini, President and CEO of GE HealthCare, emphasized the company's responsibility in addressing barriers to care and health inequities.
The program will support organizations including Milwaukee Habitat for Humanity, Boys & Girls Club of Greater Milwaukee, Feeding America Eastern Wisconsin, Milwaukee Parks Foundation, and the African American Breastfeeding Network, among others.
GE HealthCare (Nasdaq: GEHC) has introduced Hospital Pulse, a new tile for its Command Center Software Platform. This innovative tool provides real-time operational insights across hospital departments, enabling quick adjustments throughout the day. Duke Health, a Command Center Software user since 2019, will be the first to implement Hospital Pulse Tile globally.
The tile offers customizable dashboards that display vital operational metrics, such as emergency department admissions and post-anesthesia boarding times. It aims to enhance hospital efficiency, support care teams, and improve patient experience. Duke Health has already seen significant improvements, including a 66% decrease in bed request to bed assigned time and a 50% reduction in temporary labor requirements since 2020.
Hospital Pulse Tile will be widely available to U.S. customers next year, joining other Command Center Tiles like Patient Placement Prioritizer and ED Expediter. This addition further strengthens GE HealthCare's AI-enabled portfolio of digital enterprise offerings.
GE HealthCare and University Medicine Essen (UME) are collaborating to establish a new Theranostics Center of Excellence in Europe. This initiative aims to advance personalized medicine and improve cancer treatment through theranostics, a transformative approach combining targeted therapy with precise diagnostic tools.
The center will be equipped with cutting-edge technologies from GE HealthCare, including PET/CT, PET/MR, and SPECT/CT systems, as well as digital and AI solutions. These technologies will support both clinical practice and advanced research in personalized cancer care.
Key objectives of the collaboration include:
- Expanding production and access to radioisotopes for precise disease diagnosis and monitoring
- Outfitting facilities with innovative technologies for improved image quality and personalized treatment recommendations
- Supporting research activities, including collaboration on GE HealthCare's total body PET/CT technology
This partnership aims to drive innovation in clinical collaboration, research, and education throughout the region, ultimately offering more personalized treatments to cancer patients.
GE HealthCare (Nasdaq: GEHC) has launched the Versana Premier™, the latest addition to its Versana ultrasound family. This multi-purpose ultrasound system is designed for healthcare professionals across various clinical specialties, including general practice, OBGYN, musculoskeletal, and cardiology.
Key features of the Versana Premier include:
- Advanced automation and AI-enabled productivity tools
- VisionBoost Architecture for exceptional image quality
- Whizz technology for real-time image optimization
- Enhanced 3D/4D imaging capabilities for OBGYN
- AI-powered labeling and measurement tools
The system offers up to 38% faster workflow with its Whizz clinical features. Versana Premier is now available in key countries globally, with U.S. shipments beginning later this month.
FAQ
What is the current stock price of GE HealthCare Technologies (GEHC)?
What is the market cap of GE HealthCare Technologies (GEHC)?
What does GE HealthCare Technologies Inc. do?
What are the main business segments of GE HealthCare?
How does GE HealthCare generate most of its revenue?
What recent advancements has GE HealthCare made?
Who are GE HealthCare's partners?
How does GE HealthCare ensure compliance?
What products does GE HealthCare offer?
What is GE HealthCare's commitment to the community?
How has GE HealthCare performed financially?
What is GE HealthCare's mission?
